Bright Minds Biosciences Inc. (DRUG)
NASDAQ: DRUG · Real-Time Price · USD
60.98
-0.57 (-0.93%)
At close: Sep 18, 2026, 4:00 PM EDT
60.59
-0.39 (-0.64%)
After-hours: Sep 18, 2026, 7:30 PM EDT
Bright Minds Biosciences Employees
Bright Minds Biosciences had 26 employees as of September 30, 2025. The number of employees increased by 25 or 2,500.00% compared to the previous year.
Employees
26
Change (1Y)
25
Growth (1Y)
2,500.00%
Revenue / Employee
n/a
Profits / Employee
-$663,789
Market Cap
602.76M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 26 | 25 | 2,500.00% |
| Sep 30, 2024 | 1 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Valneva SE | 620 |
| Phathom Pharmaceuticals | 371 |
| ProKidney | 231 |
| CorMedix | 191 |
| Allogene Therapeutics | 152 |
| MapLight Therapeutics | 133 |
| Scribe Therapeutics | 82 |
| CytomX Therapeutics | 69 |
DRUG News
- 16 days ago - Bright Minds Biosciences to Present at Upcoming Conferences - GlobeNewsWire
- 5 weeks ago - Bright Minds Biosciences Registration statement: Q3 2026 - Filings
- 5 weeks ago - Bright Minds Biosciences Registration statement: Q3 2026 - Filings
- 7 weeks ago - Vistagen Appoints Douglas J. Williamson to its Board of Directors - GlobeNewsWire
- 2 months ago - New Options Listings: Bright Minds Biosciences (DRUG) - GuruFocus
- 3 months ago - Bright Minds Biosciences Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 3 months ago - Bright Minds Biosciences to Present at Jefferies Global Healthcare Conference - GlobeNewsWire
- 4 months ago - Why a $5 Million New Position Signals Confidence in This Epilepsy Drug Pipeline - The Motley Fool